| pubmed-article:11064622 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11064622 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:11064622 | lifeskim:mentions | umls-concept:C0592511 | lld:lifeskim |
| pubmed-article:11064622 | lifeskim:mentions | umls-concept:C0015846 | lld:lifeskim |
| pubmed-article:11064622 | lifeskim:mentions | umls-concept:C0143993 | lld:lifeskim |
| pubmed-article:11064622 | lifeskim:mentions | umls-concept:C0683150 | lld:lifeskim |
| pubmed-article:11064622 | lifeskim:mentions | umls-concept:C0032790 | lld:lifeskim |
| pubmed-article:11064622 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:11064622 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:11064622 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11064622 | pubmed:dateCreated | 2000-11-9 | lld:pubmed |
| pubmed-article:11064622 | pubmed:abstractText | No pharmacokinetic data are available with respect to the plasma concentrations and fentanyl or sufentanil during epidural administration in children. This double-blind randomized study included 12 children (5-12 yr). Patients in group F were given an epidural loading dose of fentanyl 1.5 micrograms kg-1 and in group S sufentanil 0.6 microgram kg-1. Both groups then received a continuous epidural infusion of bupivacaine 5 mg kg-1 day-1 with either fentanyl 5 micrograms kg-1 day-1 or sufentanil 2 micrograms kg-1 day-1. An epidural PCA system was also given to the children (bolus: bupivacaine 0.2 mg kg-1 and fentanyl 0.2 microgram kg-1 or sufentanil 0.08 microgram kg-1). Maximal median concentrations of plasma (0.117-0.247 ng ml-1 for fentanyl and 0.027-0.074 ng ml-1 for sufentanil) were reached approximately 30 and 20 min respectively after the loading doses. These values were similar to those measured after 48 h. | lld:pubmed |
| pubmed-article:11064622 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11064622 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11064622 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11064622 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11064622 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11064622 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11064622 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11064622 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11064622 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11064622 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11064622 | pubmed:issn | 0007-0912 | lld:pubmed |
| pubmed-article:11064622 | pubmed:author | pubmed-author:PinaudMM | lld:pubmed |
| pubmed-article:11064622 | pubmed:author | pubmed-author:LevronJ CJC | lld:pubmed |
| pubmed-article:11064622 | pubmed:author | pubmed-author:LejusCC | lld:pubmed |
| pubmed-article:11064622 | pubmed:author | pubmed-author:Le MoingJ PJP | lld:pubmed |
| pubmed-article:11064622 | pubmed:author | pubmed-author:SchwoererDD | lld:pubmed |
| pubmed-article:11064622 | pubmed:author | pubmed-author:FurieKK | lld:pubmed |
| pubmed-article:11064622 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11064622 | pubmed:volume | 85 | lld:pubmed |
| pubmed-article:11064622 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11064622 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11064622 | pubmed:pagination | 615-7 | lld:pubmed |
| pubmed-article:11064622 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:meshHeading | pubmed-meshheading:11064622... | lld:pubmed |
| pubmed-article:11064622 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11064622 | pubmed:articleTitle | Fentanyl versus sufentanil: plasma concentrations during continuous epidural postoperative infusion in children. | lld:pubmed |
| pubmed-article:11064622 | pubmed:affiliation | Department of Anaesthesiology, Hôtel-Dieu, CHR Nantes, France. | lld:pubmed |
| pubmed-article:11064622 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11064622 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11064622 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11064622 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11064622 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
